Washington, DC September 23-24, 2015
This is a two-day conference with presentations of the latest research and pharmaceutical findings regarding pain management and migraine disease.
Participants: 80 and include representatives from CRO’s (Clinical Research Organizations), pharmaceutical companies and basic researchers – no clinicians
Range of topics
New animal and human study models
New clinical measurements of pain
New directions in pathophysiology